HSIC
Price
$70.60
Change
-$0.60 (-0.84%)
Updated
Nov 19 closing price
Capitalization
8.31B
90 days until earnings call
Intraday BUY SELL Signals
SNYR
Price
$2.34
Change
+$0.18 (+8.33%)
Updated
Nov 19 closing price
Capitalization
26.33M
Intraday BUY SELL Signals
Interact to see
Advertisement

HSIC vs SNYR

Header iconHSIC vs SNYR Comparison
Open Charts HSIC vs SNYRBanner chart's image
Henry Schein
Price$70.60
Change-$0.60 (-0.84%)
Volume$1.16M
Capitalization8.31B
Synergy CHC
Price$2.34
Change+$0.18 (+8.33%)
Volume$88.21K
Capitalization26.33M
HSIC vs SNYR Comparison Chart in %
HSIC
Daily Signal:
Gain/Loss:
SNYR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HSIC vs. SNYR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HSIC is a Hold and SNYR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (HSIC: $70.60 vs. SNYR: $2.34)
Brand notoriety: HSIC and SNYR are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: HSIC: 72% vs. SNYR: 84%
Market capitalization -- HSIC: $8.31B vs. SNYR: $26.33M
HSIC [@Medical Distributors] is valued at $8.31B. SNYR’s [@Medical Distributors] market capitalization is $26.33M. The market cap for tickers in the [@Medical Distributors] industry ranges from $105.22B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HSIC’s FA Score shows that 0 FA rating(s) are green whileSNYR’s FA Score has 0 green FA rating(s).

  • HSIC’s FA Score: 0 green, 5 red.
  • SNYR’s FA Score: 0 green, 5 red.
According to our system of comparison, SNYR is a better buy in the long-term than HSIC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HSIC’s TA Score shows that 5 TA indicator(s) are bullish while SNYR’s TA Score has 5 bullish TA indicator(s).

  • HSIC’s TA Score: 5 bullish, 5 bearish.
  • SNYR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNYR is a better buy in the short-term than HSIC.

Price Growth

HSIC (@Medical Distributors) experienced а -3.08% price change this week, while SNYR (@Medical Distributors) price change was +10.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -2.60%. For the same industry, the average monthly price growth was -4.04%, and the average quarterly price growth was -0.19%.

Reported Earning Dates

HSIC is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Medical Distributors (-2.60% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HSIC($8.31B) has a higher market cap than SNYR($26.3M). HSIC has higher P/E ratio than SNYR: HSIC (22.27) vs SNYR (8.36). HSIC YTD gains are higher at: 2.023 vs. SNYR (-46.818). HSIC has higher annual earnings (EBITDA): 932M vs. SNYR (8.8M). HSIC has more cash in the bank: 145M vs. SNYR (1.46M). SNYR has less debt than HSIC: SNYR (26.9M) vs HSIC (3.36B). HSIC has higher revenues than SNYR: HSIC (12.8B) vs SNYR (33.7M).
HSICSNYRHSIC / SNYR
Capitalization8.31B26.3M31,601%
EBITDA932M8.8M10,592%
Gain YTD2.023-46.818-4%
P/E Ratio22.278.36266%
Revenue12.8B33.7M37,982%
Total Cash145M1.46M9,938%
Total Debt3.36B26.9M12,483%
FUNDAMENTALS RATINGS
HSIC vs SNYR: Fundamental Ratings
HSIC
SNYR
OUTLOOK RATING
1..100
215
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
9081
SMR RATING
1..100
65100
PRICE GROWTH RATING
1..100
4965
P/E GROWTH RATING
1..100
7634
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYR's Valuation (55) in the null industry is in the same range as HSIC (72) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to HSIC’s over the last 12 months.

SNYR's Profit vs Risk Rating (81) in the null industry is in the same range as HSIC (90) in the Medical Distributors industry. This means that SNYR’s stock grew similarly to HSIC’s over the last 12 months.

HSIC's SMR Rating (65) in the Medical Distributors industry is somewhat better than the same rating for SNYR (100) in the null industry. This means that HSIC’s stock grew somewhat faster than SNYR’s over the last 12 months.

HSIC's Price Growth Rating (49) in the Medical Distributors industry is in the same range as SNYR (65) in the null industry. This means that HSIC’s stock grew similarly to SNYR’s over the last 12 months.

SNYR's P/E Growth Rating (34) in the null industry is somewhat better than the same rating for HSIC (76) in the Medical Distributors industry. This means that SNYR’s stock grew somewhat faster than HSIC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HSICSNYR
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
41%
Bullish Trend 1 day ago
65%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
38%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
44%
Bearish Trend 1 day ago
60%
Advances
ODDS (%)
Bullish Trend 10 days ago
50%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
39%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
HSIC
Daily Signal:
Gain/Loss:
SNYR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PVLA97.0814.14
+17.05%
Palvella Therapeutics Inc
FLX3.260.34
+11.64%
BingEx Ltd.
MC61.330.35
+0.57%
Moelis & Company
FTNT79.73-0.42
-0.52%
Fortinet
ZSPC0.61-0.17
-21.53%
ZSPACE Inc

HSIC and

Correlation & Price change

A.I.dvisor tells us that HSIC and ZYXI have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HSIC and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HSIC
1D Price
Change %
HSIC100%
-0.84%
ZYXI - HSIC
30%
Poorly correlated
+32.14%
OMI - HSIC
16%
Poorly correlated
-5.54%
QIPT - HSIC
16%
Poorly correlated
-1.78%
MCK - HSIC
12%
Poorly correlated
-0.96%
SHTDY - HSIC
11%
Poorly correlated
-1.29%
More

SNYR and

Correlation & Price change

A.I.dvisor tells us that SNYR and COSM have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYR and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYR
1D Price
Change %
SNYR100%
+8.33%
COSM - SNYR
2%
Poorly correlated
-6.24%
ZYXI - SNYR
-1%
Poorly correlated
+32.14%
CAH - SNYR
-3%
Poorly correlated
+0.27%
QIPT - SNYR
-5%
Poorly correlated
-1.78%
HSIC - SNYR
-7%
Poorly correlated
-0.84%
More